LOBESITY INVESTORS
Lobesity Investors is a pharmaceutical company that specializes in providing pharmaceutical products designed to cure obesity. Its driven by its mission is the development of innovative therapies to treat obesity and either related disorders.
LOBESITY INVESTORS
Industry:
Health Care Health Diagnostics Pharmaceutical
Founded:
2015-01-01
Address:
Beachwood, Ohio, United States
Country:
United States
Website Url:
http://www.lobesitypharma.com
Total Employee:
11+
Status:
Active
Total Funding:
722.5 K USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Official Site Inspections
http://www.lobesitypharma.com
Unable to get host informations!!!
More informations about "Lobesity Investors"
Lobesity 2025 Company Profile: Valuation, Investors
Lobesity General Information Description. Developer of pharmaceutical products designed to prevent obesity. The company engages in the development and discovery of therapies for non-alcoholic fatty liver disease, hepatic steatosis, …See details»
Lobesity - Headquarter Location, Corporate Office Address and …
Corporate Office and Headquarter Office address: 11000 Cedar Avenue Cleveland, OH 44106-3052 United States. Phone number: PrivateSee details»
Lobesity Investors - Crunchbase Company Profile & Funding
Lobesity Investors is a pharmaceutical company that specializes in providing pharmaceutical products designed to cure obesity. Its driven by its mission is the development of innovative …See details»
Lobesity Company Profile - Office Locations, Competitors ... - Craft
Lobesity has 5 employees at their 1 location and $722.5 k in total funding,. See insights on Lobesity including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Lobesity - Overview, News & Similar companies | ZoomInfo.com
View Lobesity (www.lobesitypharma.com) location in Ohio, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Lobesity - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Daniel Lewis - Chief Executive Officer - Lobesity - ZoomInfo
Chief Executive Officer at Lobesity. Daniel Lewis is the Chief Executive Officer at Lobesity based in Cleveland, Ohio. Daniel received a bachelor's degree degree from Kent State Unive rsity …See details»
Lobesity Investors LLC - Drug pipelines, Patents, Clinical trials
Explore Lobesity Investors LLC with its drug pipeline, therapeutic area, technology platform, .See details»
lobesitypharma.com
Lobesitypharma.comSee details»
Ozempic And Wegovy Rivals: Here Are The Companies Working …
Jul 16, 2024 Ozempic maker Novo Nordisk and Mounjaro maker Eli Lilly dominate the lucrative weight loss drug market with Wegovy and Zepbound, but companies are racing to compete in …See details»
Lobesity Investors LLC (Lobesity Investors LLC) - 药物管线_专利_临 …
了解Lobesity Investors LLC (Lobesity Investors LLC)公司的药物管线，治疗领域，技术平台，以及它的。See details»
9 Meters Acquires Investigational Therapy NM-136
Jul 20, 2021 The therapy candidate, now known as NM-136 (formerly LOB-0136), aims to reduce obesity among Prader-Willi syndrome patients.See details»
Lobesitypharma Cyber Security Rating & Vendor Risk Report ...
View Lobesitypharma's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving LobesitypharmaSee details»
9 Meters Biopharma, Inc. Announces the Acquisition of ... - BioSpace
Jul 19, 2021 About 9 Meters Biopharma. 9 Meters Biopharma, Inc. ("the Company") is a rare and unmet needs-focused gastroenterology company. The Company is advancing vurolenatide, a …See details»
Exclusive: WHO to back use of weight-loss drugs for adults …
6 days ago The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first time, a memo reviewed by Reuters on Thursday showed, …See details»
www.lobesitypharma.com
Www.lobesitypharma.comSee details»
Six biotech companies that could revolutionize obesity treatments
Sep 5, 2024 After 48 weeks of receiving pemvidutide, patients saw a decrease in weight loss by 10.3%, 11.2%, 15.6% and 2.2% with 1.2 mg, 1.8 mg, and 2.4 mg doses and placebo …See details»
2024 was a record year for obesity trials and 2025 is already …
Jan 13, 2025 Association in 2013, despite affecting around 74% of the US population, according to the National Institutes of Health. This reinforces the World Health Organization’s …See details»
Lobesity-Lobesity LLC-企业详情-InvestGO数据库-ByDrug-医药魔 …
Dec 31, 2014 查看医药魔方InvestGO®数据库Lobesity的公司信息。Lobesity（Lobesity LLC），公司简介：See details»
Managing obesity in children: a clinical practice guideline
Apr 14, 2025 Background: Obesity is a complex, chronic, stigmatized disease whereby abnormal or excess body fat may impair health or increase the risk of medical complications, and can …See details»